Lamivudine And Zidovudine Tablet, Film Coated
Product Images NDC 76282-115

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lamivudine And Zidovudine (NDC 76282-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7.5mg-100 (Mm1)

Label for Lamivudine and Zidovudine Tablets USP with strengths of 150 mg and 300 mg respectively. The film-coated oral tablets are supplied in a 60-count bottle. The label shows the NDC number 76282-115-60, and the product is manufactured by Ascent Pharmaceuticals, Inc., for Exelan Pharmaceuticals, Inc.*

FDA Label Image

Lamivudine Chemical Structure (Mm2)

Chemical structure of Lamivudine, an active ingredient in the Lamivudine and Zidovudine combination drug. The structure shows the molecular configuration with nitrogen, oxygen, sulfur, and hydroxyl groups characteristic of Lamivudine.*

FDA Label Image

Zidovudine Chemical Structure (Mm3)

Chemical structure diagram of the active ingredient Lamivudine and Zidovudine, showing the molecular arrangement of atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.